UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of Leptin and iNOS in Oral Melanomas in Dogs

Journal of veterinary internal medicine, 2013-09, Vol.27 (5), p.1278-1282

2013

Volltextzugriff (PDF)

Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival

Clinical cancer research, 2000-12, Vol.6 (12), p.4768-4775

2000

Volltextzugriff (PDF)

Regulation of iNOS by the p44 42 mitogen-activated protein kinase pathway in human melanoma

Oncogene, 2006-06, Vol.25 (28), p.3956-3962

2006

Volltextzugriff (PDF)

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

Clinical cancer research, 1997-12, Vol.3 (12), p.2371-2376

1997

Volltextzugriff (PDF)

Phase II trial of 5‐fluorouracil, interferon‐α and continuous infusion interleukin‐2 for patients with metastatic renal cell carcinoma

Cancer, 1997-12, Vol.80 (11), p.2128-2132

1997

Volltextzugriff (PDF)

Coincident renal cell carcinoma and nonHodgkin's lymphoma : The M. D. Anderson experience and review of the literature

The Journal of urology, 1998-03, Vol.159 (3), p.714-717

1998

Volltextzugriff (PDF)

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

Oncology reports, 1999-09, Vol.6 (5), p.1097

1999

Volltextzugriff (PDF)

Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.3114-3119

2006

Volltextzugriff (PDF)

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2272-2277

1995

Volltextzugriff (PDF)

Melanoma metastatic to the spine: a review of 133 cases

Melanoma research, 2000-02, Vol.10 (1), p.78-80

2000

Volltextzugriff (PDF)

Intraabdominal desmoplastic small cell tumor: Report and discussion of five cases

Cancer, 1996-08, Vol.78 (4), p.845-851

1996

Volltextzugriff (PDF)

Loss of MDA-7 Expression With Progression of Melanoma

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1069-1074

Ellerhorst, J. A.

2002

Volltextzugriff (PDF)

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

Journal of clinical oncology, 1994-04, Vol.12 (4), p.683-688

1994

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Clinical cancer research, 2002-05, Vol.8 (5), p.1038-1044

2002

Volltextzugriff (PDF)

Phase II Trial of Low Dose γ-Interferon in Metastatic Renal Cell Carcinoma

The Journal of urology, 1994-09, Vol.152 (3), p.841-845

1994

Volltextzugriff (PDF)

Phase II evaluation of bryostatin-1 in metastatic melanoma

Melanoma research, 2001-04, Vol.11 (2), p.183-188

2001

Volltextzugriff (PDF)

Autoimmunity and hypothyroidism in patients with uveal melanoma

Melanoma research, 2001-12, Vol.11 (6), p.633-637

2001

Volltextzugriff (PDF)

Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas

International journal of cancer, 2001-10, Vol.94 (1), p.54-59

2001

Volltextzugriff (PDF)

MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 Family

International immunopharmacology, 2004-05, Vol.4 (5), p.649-667

2004

Volltextzugriff (PDF)

Whole brain irradiation for patients with metastatic melanoma: A review of 87 cases

International journal of radiation oncology, biology, physics, 2001, Vol.49 (1), p.93-97

2001

Volltextzugriff (PDF)

2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation

British journal of cancer, 1993-02, Vol.67 (2), p.209-215

1993

Volltextzugriff (PDF)

A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinoma

Annals of oncology, 1995-11, Vol.6 (9), p.911-914

1995

Volltextzugriff (PDF)

Loss of MDA-7 expression with progression of melanoma

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1069-1074

2002

Volltextzugriff (PDF)

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

Cancer, 2000-04, Vol.88 (7), p.1703

2000

Volltextzugriff (PDF)

Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma

Journal of interferon & cytokine research, 2001-04, Vol.21 (4), p.257-263

2001

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

Humans
(57)
Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Male
(36)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Oncology
(32)
Middle Aged
(31)
Female
(29)
Adult
(27)
Aged
(26)
Pharmacology. Drug Treatments
(18)
Antineoplastic Agents
(16)
Neoplasm Metastasis
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Nursing
(12)
Chemotherapy
(10)
Melanoma - Pathology
(9)
Treatment Outcome
(9)
Urology & Nephrology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of Leptin and iNOS in Oral Melanomas in Dogs

Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival

Regulation of iNOS by the p44 42 mitogen-activated protein kinase pathway in human melanoma

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

Phase II trial of 5‐fluorouracil, interferon‐α and continuous infusion interleukin‐2 for patients with metastatic renal cell carcinoma

Coincident renal cell carcinoma and nonHodgkin's lymphoma : The M. D. Anderson experience and review of the literature

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

Melanoma metastatic to the spine: a review of 133 cases

Intraabdominal desmoplastic small cell tumor: Report and discussion of five cases

Loss of MDA-7 Expression With Progression of Melanoma

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Phase II Trial of Low Dose γ-Interferon in Metastatic Renal Cell Carcinoma

Phase II evaluation of bryostatin-1 in metastatic melanoma

Autoimmunity and hypothyroidism in patients with uveal melanoma

Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas

MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 Family

Whole brain irradiation for patients with metastatic melanoma: A review of 87 cases

2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation

A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinoma

Loss of MDA-7 expression with progression of melanoma

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma

Aktive Filter

Suchergebnisse filtern